A comprehensive toxicity evaluation in rats after long-term oral Gelsemium elegans exposure

Biomed Pharmacother. 2021 May:137:111284. doi: 10.1016/j.biopha.2021.111284. Epub 2021 Feb 6.

Abstract

Background: Gelsemium elegans (G. elegans) is a flowering plant of the Loganiaceae family, which had been used in traditional Chinese herb medicine for many years for the treatment of rheumatoid pain, neuropathic pain, spasticity, skin ulcers, anxiety and cancer. Acute toxicity of the plant severely limits the application and development of G. elegans; however, long-term toxicity of exposure to G. elegans has not been illuminated.

Purpose: This study is a comprehensive observation of the effects of long-term exposure (21 days at 70 mg/kg) to G. elegans in rats.

Methods and results: The histopathological examination showed only a mild glial cell proliferation in the brain, and no lesions were observed in other organs. No abnormal changes in the biochemical parameters were observed that would have significant effects. The identification and analysis of absorbed natural ingredients showed that the active ingredients of the G. elegans could distribute to various tissues, and six compounds were identified in the brain, suggesting that they could cross the blood-brain barrier. Based on the intestinal content metabolomics, the tryptophan (Trp) biosynthesis, bile acid synthesis and bile secretion pathways have attracted our attention. Plasma metabolomic results showed that uric acid (UA) was significantly increased. The results of the brain metabolomic tests showed that the level of pyridoxal (PL) was decreased; considering the expression levels of the related enzymes, it was hypothesized that the level of pyridoxal 5'-phosphate (PLP) was decreased. PLP was important for the regulation of the neuronal γ-aminobutyric acid (GABA)/glutamate (Glu) interconversion and therefore neuronal excitability. The data of the study suggested that toxic reaction caused by G. elegans was due to a disruption of the balance of the neurotransmitter GABA/Glu transformation.

Conclusions: Overall, G. elegans did not cause significant toxic reaction in the rats after long-term exposure. The results were significant for the future clinical applications of G. elegans and suggested that G. elegans could be potentially developed as a drug. The study provided a scientific basis for investigation of the mechanisms of toxicity and detoxification.

Keywords: Gelsemium elegans; Glutamate; Metabolomics; Vitamin B6; γ-aminobutyric acid.

MeSH terms

  • Administration, Oral
  • Animals
  • Brain / drug effects*
  • Brain / metabolism
  • Brain / pathology
  • Cell Proliferation / drug effects
  • Gelsemium / toxicity*
  • Glutamic Acid / metabolism
  • Male
  • Metabolome / drug effects
  • Metabolomics
  • Neuroglia / drug effects*
  • Neuroglia / metabolism
  • Neuroglia / pathology
  • Plant Extracts / administration & dosage
  • Plant Extracts / toxicity*
  • Rats
  • Rats, Sprague-Dawley
  • Risk Assessment
  • Time Factors
  • Toxicity Tests, Chronic*
  • gamma-Aminobutyric Acid / metabolism

Substances

  • Plant Extracts
  • Glutamic Acid
  • gamma-Aminobutyric Acid